BURTON G. MALKIEL

Insider Reports History

Location
Newark, NJ
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BURTON G. MALKIEL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. Director Ordinary Shares 100,589 $1,035,061 $10.29 02 May 2023 Direct
Theravance Biopharma, Inc. Director Ordinary Shares 15,000 $154,350 $10.29 02 May 2023 By Spouse
Theravance Biopharma, Inc. Director Share Option (Right to Buy) 22,044 02 May 2023 Direct

Insider Reports Filed by BURTON G. MALKIEL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TBPH Theravance Biopharma, Inc. 02 May 2023 2 $0 4 Director 04 May 2023, 18:41
TBPH Theravance Biopharma, Inc. 26 Apr 2022 2 $0 4 Director 28 Apr 2022, 21:00